Primary Biliary Cirrhosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary CirrhosisIntervention: Drug: LUM001Sponsor: Lumena Pharmaceuticals, Inc.Not yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2014 Category: Research Source Type: clinical trials

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary CirrhosisIntervention: Drug: LUM001Sponsor: ShireNot yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2014 Category: Research Source Type: clinical trials

Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, BiliaryInterventions: Drug: Obeticholic Acid (OCA); Drug: PlaceboSponsor: Intercept PharmaceuticalsRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2014 Category: Research Source Type: clinical trials

Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, BiliaryInterventions: Drug: Obeticholic Acid (OCA); Drug: PlaceboSponsor: Intercept PharmaceuticalsRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2014 Category: Research Source Type: clinical trials